Percutaneous Removal and Margin Ablation for Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2011

Conditions
Breast Cancer
Interventions
PROCEDURE

Percutaneous Removal and Margin Ablation

Patients with a diagnosis of unicentric invasive breast cancer diagnosed by IVEB will then be assigned to the next available surgery date. On that day, the patient's axillary staging will be done, followed by ablation of the biopsy cavity using RFA. The breast surgery may include lumpectomy (which will be directed with US-guidance to assure more accurate removal of the en bloc IVEB site and the margin zone of ablation) or simple mastectomy with or without reconstruction. The tissue specimen will be sent immediately from the operating room to Pathology for routine processing.

Trial Locations (1)

72205

University of Arkansas For Medical Sciences, Little Rock

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

collaborator

Ethicon Endo-Surgery

INDUSTRY

collaborator

RITA Medical Systems

INDUSTRY

lead

University of Arkansas

OTHER